Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Amgen Inc (AMGN)  
$318.15 9.99 (3.24%) as of 4:30 Mon 6/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 585,690,000
Market Cap: 186.34(B)
Last Volume: 3,388,705 Avg Vol: 2,717,833
52 Week Range: $218.65 - $324.56
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 100     S&P 500
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  499
Guru Rank Value     : 3
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA™ (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 2,117 2,117 23,771 31,503
Total Sell Value $662,802 $662,802 $6,471,520 $8,438,219
Total People Sold 1 1 3 6
Total Sell Transactions 1 1 4 8
End Date 2024-03-24 2023-12-22 2023-06-23 2022-06-23

   
Records found: 2206
  Page 39 of 89  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Piacquad David SVP, Business Development   •       •      –    2014-04-27 4 D $111.41 $29,969 D/D (269) 27,604     -
   Patton Cynthia M SVP & CCO   •       •      –    2014-04-27 4 D $111.41 $21,168 D/D (190) 18,185     -
   Mcnamee Brian M EVP   •       •      –    2014-04-27 4 D $111.41 $84,894 D/D (762) 77,091     -
   Michael A Kelly Acting CFO   •       •      –    2014-04-27 4 D $111.41 $16,266 D/D (146) 43,106     -
   Hooper Anthony C EVP, Global Commercial Ops.   •       •      –    2014-04-27 4 D $111.41 $172,240 D/D (1,546) 114,664     -
   Harper Sean E EVP, Research & Development   •       •      –    2014-04-27 4 D $111.41 $172,240 D/D (1,546) 73,407     -
   Balachandran Madhavan EVP, Operations   •       •      –    2014-04-27 4 GD $0.00 $0 D/D 1,612 43,145     -
   Balachandran Madhavan EVP, Operations   •       •      –    2014-04-27 4 GA $0.00 $0 I/I 1,612 41,743     -
   Balachandran Madhavan EVP, Operations   •       •      –    2014-04-27 4 D $111.41 $47,795 D/D (429) 44,757     -
   Dittrich Thomas J.w. VP, Finance & CAO   •       •      –    2014-04-27 4 D $111.41 $29,524 D/D (265) 18,589     -
   Bradway Robert A Chairman, CEO and President   •       •      –    2014-04-27 4 D $111.41 $416,785 D/D (3,741) 184,119     -
   Tross Stuart A SVP, Human Resources   •       •      –    2014-04-26 4 D $111.41 $15,263 D/D (137) 30,375     -
   Scott David J SVP, Gen. Counsel & Secy.   •       •      –    2014-04-26 4 D $111.41 $80,549 D/D (723) 89,648     -
   Patton Cynthia M SVP & CCO   •       •      –    2014-04-26 4 D $111.41 $5,571 D/D (50) 18,375     -
   Mcnamee Brian M EVP   •       •      –    2014-04-26 4 D $111.41 $80,549 D/D (723) 77,853     -
   Michael A Kelly Acting CFO   •       •      –    2014-04-26 4 D $111.41 $12,924 D/D (116) 43,252     -
   Harper Sean E EVP, Research & Development   •       •      –    2014-04-26 4 D $111.41 $66,957 D/D (601) 74,953     -
   Balachandran Madhavan EVP, Operations   •       •      –    2014-04-26 4 D $111.41 $48,686 D/D (437) 45,186     -
   Dittrich Thomas J.w. VP, Finance & CAO   •       •      –    2014-04-26 4 D $111.41 $18,940 D/D (170) 18,854     -
   Bradway Robert A Chairman, CEO and President   •       •      –    2014-04-26 4 D $111.41 $261,702 D/D (2,349) 187,860     -
   Omenn Gilbert S Director   •       •      –    2014-04-25 4 A $0.00 $0 D/D 1,795 180,547     -
   Coffman Vance D Director   •       •      –    2014-04-25 4 A $0.00 $0 D/D 1,795 21,580     -
   Garland Greg C. Director   •       •      –    2014-04-25 4 A $0.00 $0 D/D 1,795 2,224     -
   Sugar Ronald D Director   •       •      –    2014-04-25 4 A $0.00 $0 D/D 1,795 7,017     -
   Biondi Frank Director   •       •      –    2014-04-25 4 A $0.00 $0 D/D 1,795 31,814     -
  2206 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 39 of 89
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us